(Q73766165)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11307092%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Effective treatment of pancreatic tumors with two multimutated herpes simplex oncolytic viruses (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11307092%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

P F McAuliffe

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11307092%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

W R Jarnagin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11307092%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

P Johnson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11307092%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

K A Delman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11307092%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

H Federoff

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11307092%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Y Fong

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11307092%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 November 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11307092%20AND%20SRC:MED&resulttype=core&format=json

Journal of Gastrointestinal Surgery

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11307092%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11307092%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11307092%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

580-588

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11307092%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1016/s1091-255x(00)80106-7

6 November 2019

exact match

0 references

cites work

Herpes simplex virus virulence: the functions of the gamma (1)34.5 gene

1 reference

12 December 2020

Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herpes simplex virus type-1 (G207).

1 reference

12 December 2020

Local and systemic therapy of human prostate adenocarcinoma with the conditionally replicating herpes simplex virus vector G207.

1 reference

12 December 2020

Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapies

1 reference

12 December 2020

Characterization of the antitumor immune response generated by treatment of murine tumors with recombinant adenoviruses expressing HSVtk, IL-2, IL-6 or B7-1.

1 reference

12 December 2020

The function of herpes simplex virus genes: a primer for genetic engineering of novel vectors

1 reference

12 December 2020

Combined HSV-1 recombinant and amplicon piggyback vectors: replication-competent and defective forms, and therapeutic efficacy for experimental gliomas

1 reference

12 December 2020

Selective infection and cytolysis of human head and neck squamous cell carcinoma with sparing of normal mucosa by a cytotoxic herpes simplex virus type 1 (G207).

1 reference

12 December 2020

Vaccinia virus-mediated expression of wild-type p53 suppresses glioma cell growth and induces apoptosis.

1 reference

12 December 2020

Safety-modified episomal vectors for human gene therapy.

1 reference

12 December 2020

Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccine

1 reference

12 December 2020

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

1 reference

12 December 2020

Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant

1 reference

12 December 2020

Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy.

1 reference

12 December 2020

Cancer statistics, 2000.

1 reference

12 December 2020

Use of a "replication-restricted" herpes virus to treat experimental human malignant mesothelioma

1 reference

12 December 2020

Genetically Engineered Attenuated Herpes Simplex Viruses

1 reference

12 December 2020

Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation of intracerebral injection in nonhuman primates.

1 reference

12 December 2020

G207, modified herpes simplex virus type 1, kills human pancreatic cancer cells in vitro

1 reference

12 December 2020

Newcastle disease virus as an antineoplastic agent: induction of tumor necrosis factor-alpha and augmentation of its cytotoxicity

1 reference

12 December 2020

An oncolytic herpes simplex virus type 1 selectively destroys diffuse liver metastases from colon carcinoma

1 reference

12 December 2020

Replication-competent, nonneuroinvasive genetically engineered herpes virus is highly effective in the treatment of therapy-resistant experimental human tumors

1 reference

12 December 2020

In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020. II. Studies in immunocompetent and immunosuppressed owl monkeys (Aotus trivirgatus)

1 reference

12 December 2020

In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020: construction and evaluation in rodents

1 reference

12 December 2020

Directed enzyme pro-drug gene therapy for pancreatic cancer in vivo.

1 reference

12 December 2020

Herpes simplex viruses

1 reference

12 December 2020

Treatment of human breast cancer in a brain metastatic model by G207, a replication-competent multimutated herpes simplex virus 1.

1 reference

12 December 2020

Antitumor efficacy of regional oncolytic viral therapy for peritoneally disseminated cancer

1 reference

12 December 2020

Reduction and elimination of encephalitis in an experimental glioma therapy model with attenuated herpes simplex mutants that retain susceptibility to acyclovir

1 reference

12 December 2020

Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas

1 reference

12 December 2020